Google TrendARSENAL (5000+) — Arsenal v Lille: Champions League – live
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Armata Pharmaceuticals Re" (17 stories)

Top Headline Story

ARMP Stock Pops As Peer-Reviewed Phage Data Backs Late-Stage Program
Lead StoryStocksToTrademarkets
Sep 14

ARMP Stock Pops As Peer-Reviewed Phage Data Backs Late-Stage Program

<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxQMXY5U0hVVnNPOHdtajZfZnNsZzZGRWFvd1BWUU5WS2lVSlVPcTNLZ0RkR2o1WmFfQkNDUWFYeUcwZlRXRUR5dmJXZ0pQaTh1RHh6bmNWTWJadklKSm9QZlJYYjJDeUFNMlV0V29UWHBOUXBTV3p3WXljT1VtMHBGMGRBbjNSZw?oc=5" target="_blank">ARMP Stock Pops As Peer-Reviewed Phage Data Backs Late-Stage Program</a>  <font color="#6f6f6f">StocksToTrade</font>

Real-time search volume
5000+21m ago

arsenal

Arsenal v Lille: Champions League – live

500+21m ago

anthony gordon

Anthony Gordon's first Barcelona goal, Manuel Neuer's mistake and Djed Spence's Inter debut in the Euro Debrief

2000+31m ago

montez sweat

Bears DE Montez Sweat suspended two games for violating NFL's PED policy

1000+41m ago

rob lowe

Ben Shapiro’s Star-Studded ‘Confession’ Film Includes James Franco, Rob Lowe And More

Search Results for "Armata Pharmaceuticals Re"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

16 stories displayed
Innoviva at H.C. Wainwright conference: growth shifts to specialty drugs By Investing.com
Investing.com Canadatech

Innoviva at H.C. Wainwright conference: growth shifts to specialty drugs By Investing.com

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxNVE9TeVI4LUZDRlB6UTRueUMzMUhiazVWYmJuMjFpNko4U0NELTJ0S0V0eE00T2laN0lDajVOcU9IbTEyQlFwRHl1ZlV0aTRBS001cEtBMDNYVlNaR2dDM01kNmtsMGhzVTJDVmNhY09pZ3lsUHUzVW9Xa3B3emY5XzVZdlBONEF2anFUN2VnVUNoV2tVaXBHbG1uTzA0cGptT2x1MTFNeXIzSmREVjZEaE5JQ2ZIdlBjTWxzTVYyeFcta0ZRZnRGblNn?oc=5" target="_blank">Innoviva at H.C. Wainwright conference: growth shifts to specialty drugs By Investing.com</a>  <font color="#6f6f6f">Investing.com Canada</font>

ARMATA PHARMACEUTICALS, INC._December 31, 2024
SEC.govgeneral

ARMATA PHARMACEUTICALS, INC._December 31, 2024

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQTXZhN1VUS3RCVFdTc2J6aDdVQWU4NnhSVk1vdVNqRnlJaVY0VUVWZC1rODRJWm1wLUxqcEtSU3dPQkxCeWdQUVk0dUNzUi1aUXlpVm5fazZSRERybjB3QUJhSUVRSG9YMVl2d18zSlRQWmllSDB1T0xHOERGMVdGZEQ3b0QydFEzMVFuUk51SmI?oc=5" target="_blank">ARMATA PHARMACEUTICALS, INC._December 31, 2024</a>  <font color="#6f6f6f">SEC.gov</font>

Armata Pharmaceuticals: Promising Phage Platform, But Phase 3 Is Everything (NYSE:ARMP)
Seeking Alphageneral

Armata Pharmaceuticals: Promising Phage Platform, But Phase 3 Is Everything (NYSE:ARMP)

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQTXJzQXJ3Q0lianZVVG5fZ2lyd1BNUTBZZ0hfNFM0WnJwMG9FNlgwN29NbHFqSXVWeVdWMy0wWlNLTjVEYktPZjlrMWY5dkxSTlJPU1ZnZW1DRUZzVG94ZnotVmZ6dnpmaFJnZ1U2YTF0emYxZTZ1Z3dGYlYxV2lwWmFrVUs2MW04UktFbjJyT1BQcS16dFdzX0hhRkp6MWNJVDlZLTJBNTdVc2diS21BTXhMc1g?oc=5" target="_blank">Armata Pharmaceuticals: Promising Phage Platform, But Phase 3 Is Everything (NYSE:ARMP)</a>  <font color="#6f6f6f">Seeking Alpha</font>

Bird Flu’s Human Risk Spurs Phage Therapy Research
Genetic Engineering and Biotechnology Newsgeneral

Bird Flu’s Human Risk Spurs Phage Therapy Research

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPMVlERmphcm9PdXNNcENNb1FXemJoaGQ0c1JnUlpVdnFwZGkyLWxCWF9FMm53aUE1aGxUZDFRMWRBX1JKZVJINm9ZcHZZbVVJVjdjOHgwUkJqQVdCTGJQX1c4MzhOcEVFanVvM1hnZUFyZ01ZdmhIeFMyS3l2eElNWWw4R1dESy12VThpWnotb09MQ1VvVUVzdnlQQl9RVnE1X01wdHliZw?oc=5" target="_blank">Bird Flu’s Human Risk Spurs Phage Therapy Research</a>  <font color="#6f6f6f">Genetic Engineering and Biotechnology News</font>

Antibiotics re-booted—time to kick back against drug resistance
Naturetech

Antibiotics re-booted—time to kick back against drug resistance

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBnS1ZhOC1lTFdBeXZWMUVBeDBsYXZuZU1fSmRLRlJleDB6MnphMlpsRWNMcGw4dlI3M3N3Wm43VFB5dEprdHdCRVBnUW02dnhHbmNpelgtUDhnNUJpdzJV?oc=5" target="_blank">Antibiotics re-booted—time to kick back against drug resistance</a>  <font color="#6f6f6f">Nature</font>

ARMP Stock Price and Chart — AMEX:ARMP
TradingViewmarkets

ARMP Stock Price and Chart — AMEX:ARMP

<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTFA3dmxzSTdYM25VcVFWbElUckVGVklwU1hxS1JHTkxsWm5zZndMTmxPcmJvNFVvYnNOVHFnQ092RXBJQ3lqSHphSFV5cU9BbF80M1hNd0c1aTNhZw?oc=5" target="_blank">ARMP Stock Price and Chart — AMEX:ARMP</a>  <font color="#6f6f6f">TradingView</font>

Armata Pharmaceuticals (ARMP) Stock Price, News & Analysis
MarketBeatmarkets

Armata Pharmaceuticals (ARMP) Stock Price, News & Analysis

<a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTFBPUTR1LTk2cnVPZlByS3FPUUdSTnBlZEh4ZjJyNmQtbEt3SmNWd0N1bllvUEpYejBicWRESTdGRnBiQWhqTWdYWWRXSzhhUmN4TW1PbG1UUlpoZFppMEFTTkJR?oc=5" target="_blank">Armata Pharmaceuticals (ARMP) Stock Price, News & Analysis</a>  <font color="#6f6f6f">MarketBeat</font>

Healthcare asset manager Innoviva buys another biotech at a bargain price
BioPharma Divetech

Healthcare asset manager Innoviva buys another biotech at a bargain price

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOSy1iZFU4Vng4bGlqZWVkOFUxTDhBMERJRnkwc2lGN2czNlg0ODNOdTlVVnU5R0xSeUphSGFCOUdQajRVTjZKZG1aWWNjbFQ3cndFbG1UYjRraFdBQy1wOGdVVk03M2hWbUc5V3dkbm14SV84dWlqWWQwZlpPV2tKVHVWMk56aHk0MnFEc0VvcWszcFJlUHJPX1JEUENVVk5u?oc=5" target="_blank">Healthcare asset manager Innoviva buys another biotech at a bargain price</a>  <font color="#6f6f6f">BioPharma Dive</font>

Next-generation bacteriophage therapeutic systems: CRISPR-based engineering, near-infrared bioimaging, and precision strategies for treating multidrug-resistant and extensively drug-resistant bacterial infections
Frontiersgeneral

Next-generation bacteriophage therapeutic systems: CRISPR-based engineering, near-infrared bioimaging, and precision strategies for treating multidrug-resistant and extensively drug-resistant bacterial infections

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQTFRzRlExZVpISGtpVEM3OE03eVdqdkhQRGNEUXFLWnpUdlNUOHZxQkhVUkI0ZjBtWjVad3hyamo4Q0tMVXRCcU5xVC1aT2RuSUVhb1RMNk4xekZJZEZ3c0loYkpPSXg0eWt3Mm1LckZtSmIyMlg3ck11eDhROEh1NVhjQVRiajhISGpKeXZTRjhraFl5?oc=5" target="_blank">Next-generation bacteriophage therapeutic systems: CRISPR-based engineering, near-infrared bioimaging, and precision strategies for treating multidrug-resistant and extensively drug-resistant bacterial infections</a>  <font color="#6f6f6f">Frontiers</font>

Should I buy Armata Pharmaceuticals (ARMP)
Zacks Investment Researchgeneral

Should I buy Armata Pharmaceuticals (ARMP)

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5ZTHZlQnZwMmFFR0dUVTA2OUx0OEhmelg1SlFlRWYyZm4wZnM2blVReEdTbzVIRnAtZzdaRzFhRkM5eTVSR3BobkxzTHZnQVUtekx6cmlXeGNySW91MlhYemQ5X3FDRjZfRzhJOQ?oc=5" target="_blank">Should I buy Armata Pharmaceuticals (ARMP)</a>  <font color="#6f6f6f">Zacks Investment Research</font>

What's in a clinical trial name? Breaking it down with the Brand Institute, from the acronymic to the aspirational
Fierce Pharmageneral

What's in a clinical trial name? Breaking it down with the Brand Institute, from the acronymic to the aspirational

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQREd1WlVjXzJJTGxYR1VzU3ZRRHJ5Zks2SVB1aU9GdzUwRElfNGtvZDduZ28zQUxWVXBaTm40cHpTU2JYcjJuZGx1ajlfaWJ0WmJjZ2h3WUI4ZVlQMEZDY1VSdHBrM2RBOC04Vnd4eDR0VVg3Vk5reWRCMnJGQzk5UVRlY3psTFBDQVd0N19SaGdIMGpiVklWb1lWOTF4ZTJoWDROd1pZMDQ5bUpJcEdWdXBIaW15amViVzEyZQ?oc=5" target="_blank">What's in a clinical trial name? Breaking it down with the Brand Institute, from the acronymic to the aspirational</a>  <font color="#6f6f6f">Fierce Pharma</font>

Re-evaluation of penicillin and ceftriaxone MIC results to predict susceptibility to the oral cephalosporin, cefpodoxime, in Streptococcus pneumoniae clinical isolates from the United States according to CLSI guidelines (2019–2021)
ASM Journalsworld

Re-evaluation of penicillin and ceftriaxone MIC results to predict susceptibility to the oral cephalosporin, cefpodoxime, in Streptococcus pneumoniae clinical isolates from the United States according to CLSI guidelines (2019–2021)

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTFBsY2c2ZldaSGcyVEhWT3JyVFg5TlhDZjB5aUlnbmN6SUZ5UnlPekZJU3BPdGhIV1AwdVlKb2ZpM1A3VDdlVWhTc0xsUWlkRFNDUE5ZVExPQU82RTlORHc?oc=5" target="_blank">Re-evaluation of penicillin and ceftriaxone MIC results to predict susceptibility to the oral cephalosporin, cefpodoxime, in Streptococcus pneumoniae clinical isolates from the United States according to CLSI guidelines (2019–2021)</a>  <font color="#6f6f6f">ASM Journals</font>

Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases
GeekWiretech

Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNUHBJXzEtM3ZsbTY3MDNhOXVIN2NLSHBMajVQX0VXSi1TZmJJZjJHSXFHcVpoTEh6UWJ2LU9zZnd3dHJKWFhvTC1aU1FHVkZlaVpOZjJiQ21mNVRuNE1ZZG9zSDVXNnBiTHhaMHBHX25WaEwzSjIyanZEOWJ0NmQ1WllBLU8wZ0tlNDNobm1oLV9JR0Z4UWRYY0l2ZnhTNFhQWm5LQzI1SXF1dmNyc1E?oc=5" target="_blank">Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases</a>  <font color="#6f6f6f">GeekWire</font>

Structural atlas of Pakpunavirus P7-1 reveals determinants of virion stability and genome ejection
Natureworld

Structural atlas of Pakpunavirus P7-1 reveals determinants of virion stability and genome ejection

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5mUTFSUjlVelVmSml2NEVBdU5kVDFGS3pHZ1JGZGhvQjdBc0V1Zmd3ZzNIUXNlTnVYa3B0dV9uQkwwdzJxcE5RSU80SG16b25jS0I5dmFrSGtMb25Eejg0?oc=5" target="_blank">Structural atlas of Pakpunavirus P7-1 reveals determinants of virion stability and genome ejection</a>  <font color="#6f6f6f">Nature</font>

StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market
Genetic Engineering and Biotechnology Newstech

StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPbWxhR2d3dUF6TkFzVThZdnN0VWNOSkNOcUhnNkxueVVvdGhBbFUxN0tjXzdPT1ZodnozWUtSUkVMYkpHSXNoQzVjTjFEMHM0QkdTdWFpcXZCcTg4UnBiSFlWOEhOOU9LWnlNVXEtTUUxQnZuWGR0Y2EwRGxBQUpnMHpoMWhmQnpZWE15ZnZLckw2ZC13TnhpWmNwcno1dmhOQ04takdMNHZWd2ZjU0U1d3MzdlJpVFdWWWM0SUJZaTE?oc=5" target="_blank">StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market</a>  <font color="#6f6f6f">Genetic Engineering and Biotechnology News</font>

Bacteriophage to the Future: Insights from the 3rd Bacteriophage Therapy Summit
Genetic Engineering and Biotechnology Newsgeneral

Bacteriophage to the Future: Insights from the 3rd Bacteriophage Therapy Summit

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxOb1hFUGZta01aelQ2dWVxdl90ZjYxaktiVV9Rb2dQalZwS3F1YnlDeUljLXFab3NDdTZJd2t2Z0pGdlZ4WlBKYkE2Ujlqa3NuSnhiS0M4Vjg0cmFmZ1RNb3lWeVdvdzhCUTVQV0l6VUZZY2VBVF9UX2ROWWZVZjRyMnZpNzNxWFpTM2NmblNDZDVMOXQ1Q2tzZWtPTFZHTm05dWdnRFZvanFjZUJlYW9TTDAxQ3ZMQQ?oc=5" target="_blank">Bacteriophage to the Future: Insights from the 3rd Bacteriophage Therapy Summit</a>  <font color="#6f6f6f">Genetic Engineering and Biotechnology News</font>

"Armata Pharmaceuticals Re" — Live Google News Trends & Headlines